Back to Journals » Therapeutics and Clinical Risk Management » Volume 5
Review
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Pemetrexed as first-line therapy for non-squamous non-small cell lung cancer
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
14,403 | Dovepress* | 14,403+ | 2,328 | 16,731 | |
Totals | 14,403 | 2,328 | 16,731 | ||
*Since 25 September 2009 +Since July 2016 |
View citations on Google Scholar